5-fluorouracil arterial infusion+interferon therapy for highly advanced hepatocellular carcinoma: A multicenter, randomized, phase II study

Hepatology Research

Volumn 42, Issue 2, 2012, Pages 150-165

  Monden, Morito ^a   Sakon, Masato ^b   Sakata, Yuh ^c   Ueda, Yoshitaka ^d   Hashimura, Etsuro ^d  

^a OSAKA UNIVERSITY   (Japan)

^b Nishinomiya Municipal Central Hospital   (Japan)

^c Misawa City Hospital   (Japan)

^d OTSUKA PHARMACEUTICAL CO LTD   (Japan)

Author keywords

5 fluorouracil; FAIT; Hepatic arterial infusion chemotherapy; Hepatocellular carcinoma; Interferon ; Portal vein

Indexed keywords

ALANINE AMINOTRANSFERASE; ALKALINE PHOSPHATASE; ALPHA INTERFERON; BILIRUBIN; CISPLATIN; FLUOROURACIL; GAMMA GLUTAMYLTRANSFERASE; GLUCOSE; HEMOGLOBIN; POTASSIUM; SODIUM; UREA;

ADULT; ADVANCED CANCER; AGED; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ALKALINE PHOSPHATASE BLOOD LEVEL; ANTINEOPLASTIC ACTIVITY; ARTICLE; ASCITES; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; BILIRUBIN BLOOD LEVEL; CANCER COMBINATION CHEMOTHERAPY; CANCER INVASION; CANCER PATIENT; CONTINUOUS INFUSION; CONTROLLED STUDY; DECREASED APPETITE; DIABETES MELLITUS; DRUG EFFICACY; DRUG SAFETY; DRUG WITHDRAWAL; ERYTHROCYTE COUNT; FEMALE; GAMMA GLUTAMYL TRANSFERASE BLOOD LEVEL; GLUCOSURIA; HEMOGLOBIN BLOOD LEVEL; HUMAN; HYPERCALCEMIA; HYPERURICEMIA; LEUKOCYTE COUNT; LIVER CELL CARCINOMA; LIVER FUNCTION; LYMPHOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; MULTIPLE CYCLE TREATMENT; NEUTROPHIL COUNT; PANCYTOPENIA; PHASE 2 CLINICAL TRIAL; PLEURA EFFUSION; PNEUMONIA; POTASSIUM BLOOD LEVEL; PRIORITY JOURNAL; PROGNOSIS; RANDOMIZED CONTROLLED TRIAL; SALVAGE THERAPY; SIDE EFFECT; SODIUM BLOOD LEVEL; THROMBOCYTE COUNT; TREATMENT RESPONSE; UREA BLOOD LEVEL;

EID: 84855930080     PISSN: 13866346     EISSN: 1872034X     Source Type: Journal    
DOI: 10.1111/j.1872-034X.2011.00905.x     Document Type: Article

References (17)

1. The Japan Society of Hepatology. Guide to Treatment of Chronic Hepatitis 2008. Tokyo: Bunkodo Co., Ltd., 2007.
2. The Japan Society of Hepatology. Manual for Diagnosis and Treatment of Hepatic Cancer. Tokyo: Igaku-shoin Ltd., 2007.
3. The Japan Society of Hepatology. Guideline for Diagnosis and Treatment of Hepatic Cancer on the Basis of Scientific Evidence 2009. Tokyo: Kanahara & Co., Ltd., 2009.
4. Tanaka M. Chemotherapy for hepatocellular carcinoma with portal vein tumor thrombosis - exploration for therapeutic strategies, arterial infusion or oral therapy focusing PVTT cases. Kan Tan Sui 2007; 55: 765-9.
5. Yamasaki O, Matsuyama M, Horii K etal. Indication and limitations of hepatectomy for hepatocellular carcinoma with portal vein tumor thrombosis. Kanzou 2003; 44: 211-21.
6. Llovet JM, Bustamante J, Castells A etal. Natural history of untreated nonsurgical hepatocellular carcinoma: rationale for the design and evaluation of therapeutic trials. Hepatology 1999; 29: 62-7.
7. Villa E, Moles A, Ferretti I etal. Natural history of inoperable hepatocellular carcinoma: estrogen receptor's status in the tumor is the strongest prognostic factor for survival. Hepatology 2000; 32: 233-8.
8. Yuen MF, Poon RTP, Lai CL etal. A randomized placebo-controlled study of long-acting octreotide for the treatment of advanced hepatocellular carcinoma. Hepatology 2002; 36: 687-91.
9. Sarin SK, Kumar M, Garg S, Hissar S, Pandey C, Sharma BC. High dose vitamin K3 infusion in advanced hepatocellular carcinoma. J Gastroenterol Hepatol 2006; 21: 1478-82.
10. Ota H, Nagano H, Sakon M etal. Treatment of hepatocellular carcinoma with major portal vein thrombosis by combined therapy with subcutaneous interferon-α and intra-arterial 5-fluorouracil; role of type I interferon receptor expression. Br J Cancer 2005; 93: 557-64.
11. Obi S, Yoshida H, Toune R etal. Combination therapy of intraarterial 5-fluorouracil and systemic interferon-alpha for advanced hepatocellular carcinoma with portal venous invasion. Cancer 2006; 106: 1990-7.
12. Oken MM, Creech RH, Tormey DC, Horton J. Toxicity and response criteria of the Eastern Cooperative Oncology Group. Am J Clin Oncol 1982; 5: 649-55.
13. Simon R, Wittes RE, Ellenberg SS. Randomized phase II clinical trials. Cancer Treat Rep 1985; 69: 1375-81.
14. Yamasaki T, Kurokawa F, Shirahashi H etal. Novel arterial infusion chemotherapy using cisplatin, 5-fluorouracil, and leucovorin for patients with advanced hepatocellular carcinoma. Hepatol Res 2002; 23: 7-17.
15. Yamashita T, Arai K, Sunagozaka H etal. Randomized, phase II study comparing interferon combined 5-fluorouracil plus cisplatin hepatic arterial infusion with interferon combined 5-fluorouracil hepatic arterial infusion in patients with advanced hepatocellular carcinoma. J Clin Oncol 2009; 27: 223s.
16. Katamura Y, Aikata H, Takaki S etal. Intra-arterial 5-fluorouracil/interferon combination therapy for advanced hepatocellular carcinoma with or without three-dimensional conformal radiotherapy for portal vein tumor thrombosis. J Gastroenterol 2009; 44: 492-502.
17. Yamashita T, Arai K, Kaneko S. Hepatic intraarterial infusion chemotherapy for advanced hepatocellular carcinoma. Kan Tan Sui 2007; 5: 753-63.